Richard J. Liekweg Chief Executive Officer | Saint Luke's Health System
Richard J. Liekweg Chief Executive Officer | Saint Luke's Health System
More than two in five adults in the United States are affected by obesity, a condition historically linked to heart disease and other health complications such as high blood pressure and diabetes. Recent research developments and new medications are altering the treatment landscape for obesity.
In a recent segment, Dr. James O’Keefe and Dr. Andrew Sauer from Saint Luke’s Mid America Heart Institute discussed these advancements and their impact on the medical community's understanding of obesity.
Alerts Sign-up